Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies

Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies

Bibliographic Details
Main Authors: Mark C. Genovese, Patrick Durez, Roy Fleischmann, Yoshiya Tanaka, Daniel Furst, Hisashi Yamanaka, Elena Korneva, Igor Vasyutin, Tsutomu Takeuchi
Format: Article
Language:English
Published: AVES Yayincilik 2021-07-01
Series:European Journal of Rheumatology
Online Access:https://www.eurjrheumatol.org/en/long-term-safety-and-efficacy-of-olokizumab-in-patients-with-rheumatoid-arthritis-and-inadequate-response-to-tumor-necrosis-factor-inhibitor-therapy-in-phase-ii-studies-133413

Similar Items

Similar Items